Your session is about to expire
← Back to Search
Erector Spinae Block for Post-Surgery Pain in Lung Cancer
Study Summary
This trial will test if shots of painkiller into the spine can help reduce post-surgery pain and the amount of opioids needed for patients having lung surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had complications during surgery, like unexpected bleeding or a change to open surgery.I need urgent surgery.I have had surgery to remove the outer layer of my lung.I have had a procedure to fuse my lung lining.I have had surgery to remove part of my lung.I am between 18 and 90 years old.You are allergic to local anesthetics.I have had surgery to remove parts of both my lungs.
- Group 1: Standard of Care + ESB Thoracic
- Group 2: Standard of Care
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor open for enrollment?
"Correct. The clinicaltrials.gov platform has the latest information, indicating that this experiment began on July 22nd 2022 and is actively seeking participants. Seventy individuals are needed from one medical centre to take part in the trial."
Has the ESB Thoracic device achieved clearance from the Food and Drug Administration?
"Based on our team's evaluation, ESB Thoracic has been judged to possess a relatively high safety rating of 3 due to its status as an approved phase 4 trial."
Am I eligible to participate in this research endeavor?
"The criteria for entry into this clinical trial includes the presence of thoracic neoplasms and an age range between 18-90 years old. A total of 70 patients are needed to complete the study."
Is this research project open to people below the age of eighty?
"The requirements for this research trial are that participants must be between 18 and 90 years old. In contrast, there are 337 clinical trials available to younger patients and 3671 opportunities for individuals above 65."
What is the enrollment rate for this clinical trial?
"Indeed, clinicaltrials.gov states that this research endeavour is actively enlisting participants. The original posting date of the trial was July 22nd 2022 and the last changes were made on August 29th 2022. A total of 70 people are being selected to take part in this study from one single site."
Share this study with friends
Copy Link
Messenger